New delivery system for severe aortic stenosis treatment
Part of Heart & circulation clinical trials.
This trial tests a new delivery system (VitaFlow Liberty Flex) for placing a replacement aortic valve in people with severe aortic stenosis. It is designed for patients whose heart anatomy (a steep angle between the heart and aorta) makes the procedure more challenging.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe aortic stenosis (tight aortic valve) confirmed by heart ultrasound.
- The angle between your heart and aorta is steeper than 60 degrees, which may make standard valve delivery harder.
- You have symptoms that limit your daily activities, like shortness of breath or chest pain.
- You are willing and able to sign a consent form to participate.
- You do not have active infections, recent heart attack, severe other valve disease, or blood clotting problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows how the VitaFlow heart valve works in people age 70+ who have severe, narrowed aortic valves and cannot safely get open-heart valve surgery. It’s meant to see whether the device improves outcomes and is safe over time.
This trial tests a new valve replacement device (VitaFlow Liberty) that is inserted through a tube in an artery, avoiding open-heart surgery. It is for people with severe aortic stenosis who are at high risk for traditional surgery.
This trial tests a new heart valve device (Venus-Vitae) for people with severe aortic stenosis, a condition where the heart valve is too tight. It aims to see if the device works well for patients of all surgical risk levels.
This trial studies whether a new through-the-blood-vessel heart valve (TAVR) is safe and works well for people with severe aortic stenosis who are too risky for traditional surgery. If you qualify, you would be closely followed to check your symptoms and valve function over time.
This study tests a new device called A² Flex used to replace the aortic valve without open-heart surgery. It is designed for people with severe aortic stenosis who are not good candidates for surgery and whose heart angle is steep (60 degrees or more).
This trial tests the VitaFlow Liberty device, a catheter-based treatment for people with severe aortic regurgitation (a leaky heart valve). If you have symptoms or your heart is starting to weaken, this procedure might help avoid open-heart surgery.
Hear when a new Aortic Valve Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.